Year |
Citation |
Score |
2018 |
Johnston P, Duckers E, Raval A, Cook T, Traverse J, Abraham W, Altman P, Pepine C. TCT-747 The CardiAMP Heart Failure Study: First Results from Unblinded Roll-In Phase Journal of the American College of Cardiology. 72. DOI: 10.1016/J.Jacc.2018.08.1971 |
0.309 |
|
2016 |
Hallberg K, Cook TD, Steiner PM, Clark MH. Pretest Measures of the Study Outcome and the Elimination of Selection Bias: Evidence from Three Within Study Comparisons. Prevention Science : the Official Journal of the Society For Prevention Research. PMID 27848116 DOI: 10.1007/S11121-016-0732-6 |
0.447 |
|
2013 |
Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, Maggioni AP, Cook T, Swedberg K, Burnett JC, Grinfeld L, Udelson JE, Zannad F, Gheorghiade M. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. European Heart Journal. 34: 835-43. PMID 23293303 DOI: 10.1093/Eurheartj/Ehs444 |
0.333 |
|
2011 |
Blair JE, Pang PS, Schrier RW, Metra M, Traver B, Cook T, Campia U, Ambrosy A, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Konstam MA, et al. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. European Heart Journal. 32: 2563-72. PMID 21785107 DOI: 10.1093/Eurheartj/Ehr238 |
0.312 |
|
2010 |
Wang NC, Piccini JP, Konstam MA, Maggioni AP, Traver B, Swedberg K, Udelson JE, Zannad F, Cook T, O'Connor CM, Miller AB, Grinfeld L, Gheorghiade M. Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction. American Journal of Therapeutics. 17: e78-87. PMID 20634650 DOI: 10.1097/Mjt.0B013E3181E70A65 |
0.315 |
|
2010 |
O'Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, Carson P, Haass M, Hauptman PJ, Metra M, Oren RM, Patten R, Piña I, Roth S, Sackner-Bernstein JD, ... ... Cook T, et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. American Heart Journal. 159: 841-849.e1. PMID 20435194 DOI: 10.1016/J.Ahj.2010.02.023 |
0.359 |
|
2010 |
Pang PS, Zannad F, Konstam M, Burnett J, Udelson J, Swedberg K, Grinfeld L, Maggioni AP, Cook T, Gheorghiade M. 40: Changes In the Neurohormonal Profile of Patients Hospitalized for Acute Heart Failure Syndromes During the Early Post-Discharge Period According to Early, Late, or No Heart Failure Re-Hospitalization or Mortality Events: Analysis From the EVEREST Trials Annals of Emergency Medicine. 56. DOI: 10.1016/J.Annemergmed.2010.06.070 |
0.344 |
|
2008 |
Blair JEA, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M. Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure. Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program Journal of the American College of Cardiology. 52: 1640-1648. PMID 18992654 DOI: 10.1016/J.Jacc.2008.07.056 |
0.38 |
|
2008 |
Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Traver B, Zimmer C, Orlandi C, Gheorghiade M. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. Jama. 299: 2656-66. PMID 18544725 DOI: 10.1001/Jama.299.22.2656 |
0.363 |
|
2008 |
Wang NC, Maggioni AP, Konstam MA, Krasa HB, Zannad F, Cook T, Traver B, Gheorghiade M. 246 Clinical implications of the QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from the EVEREST program European Journal of Heart Failure Supplements. 7: 58-58. DOI: 10.1016/S1567-4215(08)60158-7 |
0.327 |
|
2008 |
Blair J, Zannad F, Konstam M, Cook T, Burnett J, Grinfield L, Maggioni A, Swedberg K, Udelson J, Gheorghiade M. 35 Regional differences in baseline characteristics and outcomes in patients admitted with acute heart failure - results from the EVEREST program European Journal of Heart Failure Supplements. 7: 2-2. DOI: 10.1016/S1567-4215(08)60007-7 |
0.323 |
|
2007 |
Gheorghiade M, Konstam MA, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. Jama. 297: 1332-43. PMID 17384438 DOI: 10.1001/Jama.297.12.1332 |
0.357 |
|
2007 |
Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. Jama. 297: 1319-31. PMID 17384437 DOI: 10.1001/Jama.297.12.1319 |
0.376 |
|
2007 |
Wang NC, Zannad F, Konstam MA, Bechhofer R, Gheorghiade M, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Ouyang J, Zimmer C, Orlandi C, Maggioni AP. The QRS Interval Predicts Mortality and Re-Hospitalization in Patients Hospitalized with Worsening Heart Failure and Systolic Dysfunction Journal of Cardiac Failure. 13. DOI: 10.1016/J.Cardfail.2007.06.544 |
0.322 |
|
2007 |
Wang NC, Konstam MA, Gheorghiade M, Bechhofer R, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Ouyang J, Zimmer C, Orlandi C, Maggioni AP, Zannad F. Regional Comparison of Baseline Therapy in Patients Hospitalized for Acute Heart Failure with Systolic Dysfunction Journal of Cardiac Failure. 13. DOI: 10.1016/J.Cardfail.2007.06.515 |
0.332 |
|
2007 |
Zannad F, Wang NC, Konstam MA, Bechhofer R, Gheorghiade M, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Ouyang J, Zimmer C, Orlandi C, Maggioni AP. Regional Differences in Baseline Characteristics and Outcomes in Patients Hospitalized with Worsening Heart Failure and Systolic Dysfunction Journal of Cardiac Failure. 13. DOI: 10.1016/J.Cardfail.2007.06.323 |
0.343 |
|
2001 |
Lewis RJ, Berry DA, Cryer H, Fost N, Krome R, Washington GR, Houghton J, Blue JW, Bechhofer R, Cook T, Fisher M. Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: The diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial Annals of Emergency Medicine. 38: 397-404. PMID 11574796 DOI: 10.1067/Mem.2001.118223 |
0.315 |
|
Show low-probability matches. |